HER2 Targeting Therapies Market by Target Disease Indication (Breast Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, and Ovarian Cancer), Type of Molecule (Biologic and Small Molecule), Type of Therapy (Monotherapy, Combination Therapy and Both) and Route of Administration (Intravenous and Oral), Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2021-2030